There were 414 press releases posted in the last 24 hours and 466,179 in the last 365 days.


Please use this form to send email to PR contact of this press release:
While Cannabinoids are their specialty, CNBX Pharmaceuticals Inc.’s Value lies in Drug Discovery

Nathan Culotta
Landon Capital
+1 404-995-6671


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image